Curcumin as an add-on therapy for multiple sclerosis in patients receiving interferon-beta therapy
Search for agents for the add-on therapy of multiple sclerosis (MS) that can enhance the effect of first-line MS disease-modifying therapy (DMTs) is a very current issue. Such a boost is needed to reduce the need to switch to second-line DMTs, whose pathogenetic therapy leads to severe side effects...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Russo |
| Udgivet: |
IMA-PRESS LLC
2024-08-01
|
| Serier: | Неврология, нейропсихиатрия, психосоматика |
| Fag: | |
| Online adgang: | https://nnp.ima-press.net/nnp/article/view/2309 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
